Caisson Transcatheter Mitral Valve Replacement (TMVR) System Early Feasibility Study

Status unconfirmed · Not applicable

Conditions studied: Mitral Valve Regurgitation

In brief

The purpose of this study is to assess the safety and performance of the Caisson Interventional Transcatheter MitralValve Replacement (TMVR) system for the treatment of severe symptomatic MitralValve Regurgitation (MR).

Key facts

Study ID
NCT02768402
Run by
Caisson Interventional LLC
People needed
20
Starts
2016-06-01
Expected to finish
2023-12-01
Last updated by the study team
2020-01-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.